Lesion specimens from 118 episodes of recurrent genital herpes were used to compare herpes simplex virus (HSV) isolation with a direct specimen test for in situ DNA hybridization utilizing a biotinylated probe. The frequency of detection of HSV was similar with both tests; HSV was isolated from 81% of vesicular lesions, 76% of pustules, and 67% of ulcers, while HSV DNA was detected in 77, 76, and 55% of lesions in these stages, respectively. Utilizing both methods, HSV was identified in 91, 94, and 79%, respectively. The sensitivity and specificity of the DNA probe in, comparison to standard viral isolation in tissue culture were 92 and 63%, respectively. Seven DNA-positive, viral isolation-negative specimens were obtained from patients who had positive culture confirmation at some time subsequent or prior to enrollment, suggesting that these were true positive results. The sensitivity of the DNA probe was dependent on cellular content of the specimen, and 36 (28%) of the 127 submitted specimens had fewer than 20 nonsuperficial cells. The DNA probe was rapid and convenient; its major disadvantage was the lack of type-specific information. The performance of the probe in lower-prevalence populations and in asymptomatic shedding of HSV remains to be evaluated.
The advent of antiviral chemotherapy has made accurate and rapid diagnosis of herpes simplex virus (HSV) infections of increasing importance (3, 4, 15, 19) . No described method exceeds the sensitivity of cell culture (2) . However, virus isolation from cell culture may take up to 5 days and requires laboratory expertise in cell culture maintenance and recognition of cytopathic effect. Multiple viral antigenic detection techniques, such as enzyme-linked immunosorbent assay, immunoperoxidase, immunofluorescence, and immunohemagglutination, utilizing monoclonal antibodies, have been evaluated in an effort to expedite cell culture processing time and to detect HSV antigen from lesion samples (1, 2, 8-10, 16, 21, 22, 24, 25) . DNA hybridization has also been utilized as a rapid means of detecting HSV infection from tissue or lesion samples (5, 6, 11, 14) . In this study we evaluated the sensitivity, specificity, and ease of method of a commercially available, nonradioactive, biotinylated (12, 20) , viral DNA probe (ENZO Biochem, Inc.) and compared it with standard cell culture with monoclonal antibody confirmation. The probe is a combination of two previously described HSV DNA restriction enzyme fragments, designated Bam F probe (HSV type 1 [HSV-1]) and PDG 305 probe (HSV-2) (7, 13) . It hybridizes with both HSV-1 and HSV-2 DNA.
We found that the DNA probe performed well in a well-defined population with recurrent genital herpes, with an overall sensitivity of 92% in comparison to tissue cultures. Laboratory processing time was 2 to 2.5 h.
MATERIALS AND METHODS
Clinical population. Eighty-six patients who had a history of recurrent genital ulcerations and presented with an acute episode of probable recurrent genital herpes to a referral clinic located at the Harborview Medical Center, Seattle, Wash., were enrolled. Genital exam was performed upon enrollment, and external lesions typical of HSV infection were sampled and recorded for stage (vesicles, pustules, ulcers). Nongenital lesions suspected of HSV infection were examined and recorded separately. Specimens for both culture and DNA probe were obtained from a single lesion or a group of lesions. For sampling, the lesion was cleansed with sterile saline, and mucous was removed, if present. Vesicular or pustular lesions were opened with a 25-gauge needle, and fluid was collected and sent to the laboratory in the needle for viral isolation only. A second sample was then obtained from the base of the opened lesion by vigorously rubbing with a Dacron swab moistened with saline. Promptly after sampling, the swab was slowly rolled across the specimen area of a glass slide, allowed to air dry, fixed in acetone, and refrigerated (2 to 8°C). Ulcers were sampled with an initial swab specimen for viral isolation and transported in viral transport media, and a subsequent swab sample was obtained from the base as described for vesicles and pustules. Specimens were transported to the laboratory within 24 h.
Cultures, monoclonal antibody confirmation, and DNA probe testing were performed and evaluated without knowledge of the clinical presentation of the patient.
Cell cultures. Viral isolation methods used have been described previously (14) . In summary, 0.2-ml samples of the specimen in viral transport medium (veal Relative sensitivities of these tests varied with the stage of the disease at the time of sampling (Table 1 ). Viral isolation was positive from 81% of vesicular lesions, 76% of pustules, and 67% of ulcers. HSV DNA was detected in 77, 76, and 55% of lesions in these stages, respectively. Seven culturenegative lesions had HSV DNA detected in them (two vesicles, three pustules, and two ulcers). Conversely, HSV was isolated from 16 DNA-negative specimens. Of these 16 specimens, 9 were negative by in situ hybridization because they had inadequate numbers of cells to examine. Seven specimens (two vesicular, one pustular, and four ulcers) had adequate numbers of cells but were DNA negative. Utilizing both methods, HSV was identified in 91, 94, and 79% of vesicles, pustules, and ulcers, respectively.
Twelve samples were viral isolation positive and DNA positive, although they contained <20 nonsupèrficial cells. If these samples are included in the results, HSV DNA was identified in 88, 83, and 73% of vesicular, pustular, and ulcerative lesions, respectively. Utilizing both methods, laboratory evidence of HSV was present in 93, 94, and 82% of vesicular, pustular, and ulcerative lesions, respectively.
For samples >20 exfoliated cells on examination, the overall sensitivity of the DNA detection by in situ hybridization compared with viral isolation was 90.4%; specificity, 66.6%; positive predictive value, 92%; and negative predictive value, 63%. When we included the 12 culture-positive DNA-positive samples with <20 nonsuperficial cells, the sensitivity increased to 92%, specificity was 67%, and the predictive values remained the same as given above. Also, the sensitivity of the DNA probe for specimens from which HSV-1 was isolated (4 of 5 with >20 nonsuperficial cells, or 80%) was similar to the sensitivity for specimens from which HSV-2 was isolated (62 of 68, or 92%).
The sensitivity and specificity of the DNA detection were significantly different for specimens with inadequate cell counts compared with adequate specimens; sensitivity was 57%, specificity was 93%, positive predictive value was 92%, and negative predictive value was 61%.
The overall sensitivity of samples taken at multiple times from the same individual was similar for both assays to that seen from single samples obtained from different individuals.
Relationship between duration of lesion and sensitivity of viral isolation and DNA testing. HSV DNA was detected in 65 (71%) of 91 specimens sampled within 48 h of lesion onset, compared with 20 (56%) of 36 samples collected >48 h after lesion onset. Values for viral isolation were 79 and (17) 13 (76) 1 (6) 2 (12) 1 (6) 16 (94) Ulcer (38) 24 (63) 4 (10.5) 2 (5) 8 (21) 30 (79) Ali stages (91) 66 (73) 7 (8) 6 (6) 12 (13) antigen was identified with sensitivity of 74% and specificity 85% compared with viral isolation (9) , suggesting that the probe has equal if not greater sensitivity. Its lack of type specificity is, however, a current disadvantage.
In conclusion, HSV DNA detection appears to be a diagnostic tool with sensitivity equal to that of viral isolation when applied to a high-prevalence population with symptomatic genital lesions. It can be rapidly performed (approximately 2 h 15 min), and equipment costs are projected to be less expensive than for the direct immunofluorescence assay per specimen. Further studies are needed to assess the value of the test in lower-prevalence populations and whether it will detect asymptomatic excretion of HSV in the oral or genital tract.
